Our series consisted of nine patients with carcinoma cuniculatum diagnosed on esophagectomy specimens 6 and two patients with carcinoma cuniculatum diagnosed on endoscopic mucosal resection specimens ...

Peer-Reviewed Study Conducted in Collaboration with Mayo Clinic Demonstrates 100% Sensitivity and Strong Predictive Power for Esophageal Cancer Progression Early Access Programs and Physician ...

APPROXIMATELY 20 per cent of esophageal carcinomas are nonobstructing when first seen and many remain so throughout the course of the disease. 1–4 For this reason dysphagia, usually the most prominent ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Samuel J. Klempner ...

ROCKVILLE, Md.--(BUSINESS WIRE)--Creatv MicroTech, a privately-held biotechnology company has pioneered a blood test to predict treatment response in patients with newly diagnosed Stage I-III ...

Esophageal cancer is increasing in frequency in the United States faster than any other cancer. Barrett's esophagus, an otherwise benign complication of esophageal reflux, affects approximately three ...

UNIONDALE, NY, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced today ...

LAS VEGAS, NV--(Marketwire - Oct 22, 2012) - CDx Diagnostics announced today that new data support the use of the company's Wide Area Transepithelial Sample (WATS) 3-dimensional biopsy as an ...

Outcomes of concern for this retrospective study were eosinophilic esophagitis (EOE) mucosal biopsies, EoE diagnosis, proton pump inhibitor initiation, and recommendations being followed for repeat ...

> CDx Diagnostics said study results show its WATS3D biopsy leads to major increases in the detection of Barrett's esophagus and esophageal dysplasia, two conditions ...

Do you know about endocytoscopy? Endocytoscopy is a new type of digestive endoscopy that can diagnose small, early esophageal cancers without biopsy. Esophageal cancer is a malignant tumor originating ...

UNIONDALE, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (PRPH) today announced that its study, “Assessing Risk of Progression in Barrett’s Esophagus Using a Mass-Spectrometry-Based ...